Analysis of Fatal Cases of Pandemic Influenza A (H1N1) Virus Infections in Pediatric Patients with Leukemia

REFERENCES

• Buchfinder N, Dumensil C, Pinquier D, Pandemic A/H1N1/2009 influenza in a paediatric hematology and oncology unit succesful management of a sudden outbreak. J Hosp Infect. 2011;79:155–160.
   PubMedGoogle Scholar
• CDC. Influenza prevention and control recommendations published for the 2010–11 influenza season. Adapted for the 2012–13 Influenza Season available at http://www.cdc.gov/ flu/professionals/acip/specificpopulations.htm. Accessed 18 December 2012.
   Google Scholar
• Tran D, Science M, Dix D, Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients. Influenza Other Respi Viruses. 2012;6(6):105–133.
   Google Scholar
• Launes C, Rives S, Catala A, Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol. 2010;149:874–878.
   PubMedGoogle Scholar
• Unal Ş Gökçe M, Elmas SA, Mild to fatal course of pandemic influenza H1N1 in children with acute leukaemia. Br J Haematol. 2011;152:492–493.
   PubMedGoogle Scholar
• Malik PS, Broor S, Bakhshi S. H1N1 infection in children with hematological malignancies. Indian Pediatr. 2011;48:971–973.
   PubMedGoogle Scholar
• CDC. CDC protocol of realtime RTPCR for influenza (H1N1). http://www.who.int/ csr/resources /publications/swineflu/realtimeptpcr/en/index.html. Publication date 6 October 2009 (originally published on 30 April 2009)
   Google Scholar
• CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza. Recommendations of the advisory committee on immunization practices (ACIP). MMWR. 2011;60:1–24.
   Google Scholar
• Henter JI, Horne A, Aricó M, HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Caselli D, Carraro F, Castagnola E, Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer. 2010;55:226–228.
   PubMed Web of Science ®Google Scholar
• Tavil B, Azik F, Culha V, Pandemic H1N1 influenza infection in children with acute leukemia: a single-center experience. J Pediatr Hematol Oncol. 2012;34:48–50.
   PubMedGoogle Scholar
• Cost C, Brock E, Adams-Huet B, 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer. 2011;56:127–133.
   Google Scholar
• Karapınar DY, Ay Y, Karzaoğlu Z, Experience of pandemic influenza with H1N1 in children with leukemia. J Pediatr Hematol Oncol. 2011;28:31–36.
   Google Scholar
• Ozdemir N, Celkan T, Midilli K, Novel influenza a (H1N1) infection in a Pediatric Hematology Oncology Clinic during the 2009–2010 pandemic. Pediatr Hematol Oncol. 2011;28:288–293.
   PubMed Web of Science ®Google Scholar
• Redelman-Sidi G, Sepkowitz KA, Huang CK, 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60:257–263.
   Google Scholar
• Shah DP, El Taoum KK, Shah JN, Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J. 2012;31:373–378.
   PubMedGoogle Scholar
• Zeller B, Hellebostad M. H1N1 infection in children with haematological and oncological diseases in Norway. Acta Paediatr. 2011;100:1134–1137.
   PubMedGoogle Scholar
• Elbahlawan L, Gaur AL, Furman W, Severe H1N1 associated acute respiratory failure in immunocompromised patients. Pediatr Blood Cancer. 2011;57:625–628.
   PubMedGoogle Scholar
• Amayiri N, Madanat F. Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection. Pediatr Blood Cancer. 2011;56:86–89.
   PubMedGoogle Scholar
• Chironna M, Tafuri S, Santoro N, A nosocomial outbreak of 2009 pandemic influenza A(H1N1) in a paediatric oncology ward in Italy, October-November 2009. Euro Surveill. 2010;15(1): 19454.17.
   Google Scholar
• Liu C, Schwartz BS, Vallabhaneni S, Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis. 2010;16:1910–1917.
   PubMedGoogle Scholar
• Cheng FW, Li CH, Shing MK, Hong Kong Paediatric Haematology and Oncology Study Group. Pandemic influenza A (2009-H1N1) infection in paediatric oncology patients in Hong Kong. Br J Haematol. 2010;151:202–206.
   PubMedGoogle Scholar
• Peiris JSM, Yu WC, Leung CW, Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363:617–619.
   PubMed Web of Science ®Google Scholar
• Akcay Ciblak M, Hasoksuz M, Kanturvardar M, Molecular and serological investigations of the Influenza A(H1N1) 2009 pandemic virus in Turkey. Med Microbiol Immunol. 2013. [Epub ahead of print].
   PubMedGoogle Scholar
• El Moussi A, Ledesma J, Ben Hadj Kacem MA, Haemagglutinin D222G mutation found in a fatal case of pandemic (H1N1) flu in Tunisia. Arch Virol. 2012;157(9):1813–1814. doi: 10.1007/s00705-012-1349-0. [Epub 2012 June 9].
   PubMedGoogle Scholar
• Tse H, To KK, Wen X, Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One. 2011;6(9):e22534.
   PubMed Web of Science ®Google Scholar
• Wu C, Cheng X, Wang X, Clinical and molecular characteristics of the 2009 pandemic influenza H1N1 infection with severe or fatal disease from 2009 to 2011 in Shenzhen, China. Med Virol. 2013;85(3):405–412.
   PubMedGoogle Scholar
• Puzelli S, Facchini M, De Marco MA, Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill. 2010;15(43), pii: 19696.
   PubMedGoogle Scholar